<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML xmlns="http://www.w3.org/TR/REC-html40" xmlns:v =
"urn:schemas-microsoft-com:vml" xmlns:o =
"urn:schemas-microsoft-com:office:office" xmlns:w =
"urn:schemas-microsoft-com:office:word" xmlns:x =
"urn:schemas-microsoft-com:office:excel" xmlns:p =
"urn:schemas-microsoft-com:office:powerpoint" xmlns:a =
"urn:schemas-microsoft-com:office:access" xmlns:dt =
"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:s =
"uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs =
"urn:schemas-microsoft-com:rowset" xmlns:z = "#RowsetSchema" xmlns:b =
"urn:schemas-microsoft-com:office:publisher" xmlns:ss =
"urn:schemas-microsoft-com:office:spreadsheet" xmlns:c =
"urn:schemas-microsoft-com:office:component:spreadsheet" xmlns:odc =
"urn:schemas-microsoft-com:office:odc" xmlns:oa =
"urn:schemas-microsoft-com:office:activation" xmlns:html =
"http://www.w3.org/TR/REC-html40" xmlns:q =
"http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc =
"http://microsoft.com/officenet/conferencing" XMLNS:D = "DAV:" XMLNS:Repl =
"http://schemas.microsoft.com/repl/" xmlns:mt =
"http://schemas.microsoft.com/sharepoint/soap/meetings/" xmlns:x2 =
"http://schemas.microsoft.com/office/excel/2003/xml" xmlns:ppda =
"http://www.passport.com/NameSpace.xsd" xmlns:ois =
"http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns:dir =
"http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds =
"http://www.w3.org/2000/09/xmldsig#" xmlns:dsp =
"http://schemas.microsoft.com/sharepoint/dsp" xmlns:udc =
"http://schemas.microsoft.com/data/udc" xmlns:xsd =
"http://www.w3.org/2001/XMLSchema" xmlns:sub =
"http://schemas.microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec =
"http://www.w3.org/2001/04/xmlenc#" xmlns:sp =
"http://schemas.microsoft.com/sharepoint/" xmlns:sps =
"http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi =
"http://www.w3.org/2001/XMLSchema-instance" xmlns:udcs =
"http://schemas.microsoft.com/data/udc/soap" xmlns:udcxf =
"http://schemas.microsoft.com/data/udc/xmlfile" xmlns:udcp2p =
"http://schemas.microsoft.com/data/udc/parttopart" xmlns:wf =
"http://schemas.microsoft.com/sharepoint/soap/workflow/" xmlns:dsss =
"http://schemas.microsoft.com/office/2006/digsig-setup" xmlns:dssi =
"http://schemas.microsoft.com/office/2006/digsig" xmlns:mdssi =
"http://schemas.openxmlformats.org/package/2006/digital-signature" xmlns:mver =
"http://schemas.openxmlformats.org/markup-compatibility/2006" xmlns:m =
"http://schemas.microsoft.com/office/2004/12/omml" xmlns:mrels =
"http://schemas.openxmlformats.org/package/2006/relationships" xmlns:spwp =
"http://microsoft.com/sharepoint/webpartpages" xmlns:ex12t =
"http://schemas.microsoft.com/exchange/services/2006/types" xmlns:ex12m =
"http://schemas.microsoft.com/exchange/services/2006/messages" xmlns:pptsl =
"http://schemas.microsoft.com/sharepoint/soap/SlideLibrary/" xmlns:spsl =
"http://microsoft.com/webservices/SharePointPortalServer/PublishedLinksService"
XMLNS:Z = "urn:schemas-microsoft-com:" xmlns:st = ""><HEAD>
<META content="text/html; charset=iso-8859-1" http-equiv=Content-Type>
<META name=GENERATOR content="MSHTML 8.00.6001.18939">
<STYLE>@font-face {
font-family: Cambria Math;
}
@font-face {
font-family: Calibri;
}
@font-face {
font-family: Tahoma;
}
@font-face {
font-family: SymbolMT;
}
@page WordSection1 {size: 8.5in 11.0in; margin: 1.0in 1.25in 1.0in 1.25in; }
P.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
LI.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
DIV.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
A:link {
COLOR: blue; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.MsoHyperlink {
COLOR: blue; TEXT-DECORATION: underline; mso-style-priority: 99
}
A:visited {
COLOR: purple; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.MsoHyperlinkFollowed {
COLOR: purple; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.EmailStyle17 {
FONT-FAMILY: "Arial","sans-serif"; COLOR: windowtext; mso-style-type: personal
}
SPAN.EmailStyle18 {
FONT-FAMILY: "Calibri","sans-serif"; COLOR: #1f497d; mso-style-type: personal-reply
}
.MsoChpDefault {
FONT-SIZE: 10pt; mso-style-type: export-only
}
DIV.WordSection1 {
page: WordSection1
}
</STYLE>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></HEAD>
<BODY lang=EN-US link=blue bgColor=#ffffff vLink=purple>
<DIV><FONT size=2 face=Arial>This is for people with no light perception.
Call the number at the bottom of the email. This company was at the
national convention.</FONT></DIV>
<DIV><FONT size=2 face=Arial></FONT> </DIV>
<DIV><FONT size=2 face=Arial>Debbie</FONT></DIV>
<DIV><FONT size=2 face=Arial></FONT> </DIV>
<DIV style="FONT: 10pt arial">----- Original Message -----
<DIV style="BACKGROUND: #e4e4e4; font-color: black"><B>From:</B> <A
title=nfbmd@riccobono.us href="mailto:nfbmd@riccobono.us">National Federation of
the Blind of Maryland</A> </DIV>
<DIV><B>To:</B> <A title=63characters@comcast.net
href="mailto:63characters@comcast.net">'d'</A> </DIV>
<DIV><B>Sent:</B> Friday, October 01, 2010 7:29 AM</DIV>
<DIV><B>Subject:</B> FW: Local Study on Sleep and Blindness</DIV></DIV>
<DIV><BR></DIV>
<DIV class=WordSection1>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Hello
Debbie,<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Perhaps
this would be something of interest to your chapter
members?<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Melissa<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt"><o:p> </o:p></SPAN></P>
<DIV>
<DIV
style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; BORDER-TOP: #b5c4df 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 3pt">
<P class=MsoNormal><B><SPAN
style="FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 10pt">From:</SPAN></B><SPAN
style="FONT-FAMILY: 'Tahoma','sans-serif'; FONT-SIZE: 10pt"> Sara Dale
[mailto:Sara.Dale@vandapharma.com] <BR><B>Sent:</B> Thursday, September 30, 2010
2:03 PM<BR><B>To:</B> <A
href="mailto:president@nfbmd.org">president@nfbmd.org</A><BR><B>Subject:</B>
Local Study on Sleep and Blindness<o:p></o:p></SPAN></P></DIV></DIV>
<P class=MsoNormal><o:p> </o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Dear Ms.
Riccobono,<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">I am from Vanda
Pharmaceuticals, a Biotech Company in Rockville, MD. I see that we have
reach out to you in the past and I am emailing today because we are trying to
reach out to blind individuals and would like to know if you would be willing to
help us. We have worked closely with the NFB national offices and
have placed announcements in their publications. We are now reaching out to
local chapters as we have clinical trial sites located across the country.
I believe that some members of the Maryland Chapter of the NFB may be interested
in learning about our effort to better understand sleep problems in people who
are totally blind. <o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">We are currently
launching clinical trials to test a new experimental treatment for blind
individuals who suffer from a sleep disorder known as Non-24 Hour Sleep Wake
Disorder. In the US, this disorder affects </SPAN><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt" lang=EN>approximately
65,000 totally blind individuals who have this disorder because they lack
</SPAN><SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">the
light sensitivity necessary to reset their “body clock”. Would you be
willing to send an announcement about our clinical trials? Do you have an
email list through which we could send information?<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">We gladly welcome the
opportunity to talk to you about our plans and to learn more about you and your
organization. We also would appreciate if you could pass this information along
to other individuals in your organization and your community who may be
interested by this research<SPAN
style="COLOR: navy">.</SPAN><o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Below is an
announcement about upcoming sleep studies that some totally blind individuals
may be interested in. I have also attached a PDF of this announcement.
<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center><B><SPAN
style="FONT-SIZE: 16pt">Clinical Research Study
Recruitment<o:p></o:p></SPAN></B></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center><B><SPAN
style="FONT-SIZE: 16pt">Blind individuals with no light perception
needed.<o:p></o:p></SPAN></B></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center><B><SPAN
style="FONT-SIZE: 16pt"><o:p> </o:p></SPAN></B></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center>A local doctor is
conducting research to evaluate a new investigational treatment for insomnia and
daytime sleepiness in totally blind individuals.<o:p></o:p></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center>Individuals may
qualify who:<o:p></o:p></P>
<P style="TEXT-ALIGN: center; MARGIN-LEFT: 0.5in" class=MsoNormal
align=center><SPAN style="FONT-FAMILY: SymbolMT">• </SPAN>are between 18 and 75
years of age<o:p></o:p></P>
<P style="TEXT-ALIGN: center; MARGIN-LEFT: 0.5in" class=MsoNormal
align=center><SPAN style="FONT-FAMILY: SymbolMT">• </SPAN>are blind with no
light perception<o:p></o:p></P>
<P style="TEXT-ALIGN: center; MARGIN-LEFT: 0.5in" class=MsoNormal
align=center><SPAN style="FONT-FAMILY: SymbolMT">• </SPAN>have trouble sleeping
at night or experience daytime sleepiness<o:p></o:p></P>
<P style="TEXT-ALIGN: center; MARGIN-LEFT: 0.5in" class=MsoNormal
align=center><o:p> </o:p></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center>Qualified
participants will receive study medication and study-related medical evaluation
at no cost.<o:p></o:p></P>
<P style="TEXT-ALIGN: center" class=MsoNormal align=center><B><SPAN
style="FONT-SIZE: 16pt">For more information: Call 1-888-389-7033 </SPAN></B>M-F
9:00 AM to 5:00 PM ET<o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Thank you for your
time!<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Sara<o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Sara
Dale</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Clinical Research
Associate</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">9605 Medical Center
Dr</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Suite
300</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Rockville, MD
20850</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Tel:
240.599.4523</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Mobile:
301.768.6036</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Fax:
301.294.1900</SPAN><o:p></o:p></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">Email: </SPAN><A
href="mailto:sara.dale@vandapharma.com"><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt">sara.dale@vandapharma.com</SPAN></A><o:p></o:p></P>
<P class=MsoNormal><o:p> </o:p></P></DIV><BR><BR>__________ Information
from ESET Smart Security, version of virus signature database 5496 (20101001)
__________<BR><BR>The message was checked by ESET Smart Security.<BR><BR><A
href="http://www.eset.com">http://www.eset.com</A><BR><BR>
<BR>
__________ Information from ESET Smart Security, version of virus signature database 5498 (20101002) __________<BR>
<BR>
The message was checked by ESET Smart Security.<BR>
<BR>
<A HREF="http://www.eset.com">http://www.eset.com</A><BR>
</BODY></HTML>